DWMTS: Addressing Stress Amongst Female Entrepreneurs in Addis Ababa, Ethiopia: a Pilot Study

Sponsor
World Bank (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05208723
Collaborator
Ethiopian Medical Association (Other), Addis Ababa University (Other), PSI Ethiopia (Other)
200
1
2
29.5
6.8

Study Details

Study Description

Brief Summary

The overall objective of this study is to evaluate the impact of the "Doing What Matters in Times of Stress Guided Self-Help" handbook along with lay helper session on managing stress and emotion on mental distress and well-being. If successful, the study will assess its impact on business performance among women entrepreneurs in Ethiopia.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Stress and emotion management
N/A

Detailed Description

The overall objective of this study is to evaluate the impact of the "Doing What Matters in Times of Stress Guided Self-Help Manual" on mental distress and if successful, see its impact on business performance among women entrepreneurs in Ethiopia. The study will be conducted in Addis Ababa, Ethiopia. A pilot randomized controlled trial (RCT) will be conducted to investigate the impact of the "Doing What Matters in Times of Stress Guided Self-Help Manual" intervention to reduce psychological distress and functional impairment among women entrepreneurs in Ethiopia. The investigators will screen approximately1200 women over the phone and identify 200 eligible women for the study. An in-person baseline survey will be conducted with the 200 eligible women and the participants will be randomized (using computer generated randomization) to either the doing what matters in times of stress self-help manual intervention (n=100) or wait list control (n=100). This will be followed by 6 phone-based sessions over 6-8 weeks to review handbook materials for the intervention group only. After six weeks, phone-based follow-up survey will be conducted with participants in both the intervention and control groups. If the intervention is found to be effective in reducing distress or stress at follow-up assessment, then the baseline survey will be repeated at 6-9 months post intervention both for the intervention and control group participants. Additionally, based on findings from the pilot study a larger sample of participants will be screened and enrolled (approximately 1000 women) and randomized to the intervention or wait-list control arm to be followed up at 6-9 months post intervention. The primary outcomes for this study will be psychological distress. Participants' performance on their businesses and self-esteem will be secondary outcomes for the study. A generalized linear model with appropriate statistical specifications and accounting for baseline values and any imbalanced variables at baseline (where available) will be used to analyze the data.

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Enrolled participants are randomized to intervention or control groupEnrolled participants are randomized to intervention or control group
Masking:
Single (Investigator)
Masking Description:
Randomized using computer generated randomization at one point in time by an independent researcher
Primary Purpose:
Prevention
Official Title:
Stress and Emotion Management Training for Female Entrepreneurs in Ethiopia
Actual Study Start Date :
Jul 17, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Stress and emotion management

A locally adapted self-help guidebook originally developed by the World Health Organization (WHO), 'Doing what matters in times of stress' for managing disruptive emotions and psychological distress, will be delivered to female entrepreneurs at their residence, followed by 5-6 phone calls from a trained mental health helper to reinforce the materials over a 6-week period. The intervention is intended to help people manage their psychological distress associated with a range of adversities but is not intended for participants with severe mental health problems such as psychosis or imminent risk of suicide.

Behavioral: Stress and emotion management
The handbook materials and lay helper scripts are based on principles of Acceptance and Commitment Therapy (ACT), and aims to enhance psychological flexibility. Psychological flexibility reflects how a person adapts to fluctuating situational demands, reconfigures mental resources, shifts perspective, and balances competing needs. ACT teaches alternative methods to accommodate difficult thoughts and feelings, primarily through mindfulness techniques. At the same time, ACT also focuses on guiding participants to live in ways consistent with their personal values.
Other Names:
  • Doing what matters in times of Stress
  • Acceptance and Commitment Therapy (ACT)
  • No Intervention: Control group

    No intervention. May receive intervention post study if findings are indicative of any benefit.

    Outcome Measures

    Primary Outcome Measures

    1. Mental Distress using the Kessler Psychological Distress Scale (K-6) [4-6 weeks post intervention]

      Minimum value of 0 and a maximum value of 24. Higher scores indicate high levels of psychological distress (worse outcome)

    2. Mental Distress using the Kessler Psychological Distress Scale (K-6) [6-9 months post intervention]

      Minimum value of 0 and a maximum score of 24. Higher scores indicate high levels of psychological distress (worse outcome)

    3. Depression using the Patient Health Questionnaire (PHQ-9) [4-6 weeks post intervention]

      Minimum score 0 and a maximum score of 27. Higher scores indicate increased levels of depressive symptoms (worse outcome).

    4. Depression using the Patient Health Questionnaire (PHQ-9) [6-9 months post intervention]

      Minimum score 0 and a maximum score of 27. Higher scores indicate increased levels of depressive symptoms (worse outcome).

    5. Stress using the Perceived Stress Scale [4-6 weeks post intervention]

      Minimum score of 0 and a maximum of 40. Higher scores indicate high levels of perceived stress (worse outcome). Investigators will reverse code items 4,5, 7 and 8

    6. Stress using the Perceived Stress Scale [6-9 months post intervention]

      Minimum score of 0 and a maximum of 40. Higher scores indicate high levels of perceived stress (worse outcome). Investigators will reverse code items 4,5, 7 and 8

    7. Self-reported Business outcomes [6-9 months post intervention]

      Self-reported past month profits in local currency

    Secondary Outcome Measures

    1. Self-reported Business outcomes [4-6 weeks post intervention]

      Self-reported past month profits in local currency

    2. Self-reported Business Closure [4-6 weeks post intervention]

      Self-reported business closure

    3. Self-reported Business Closure [6-9 months post intervention]

      Self-reported business closure

    4. Self-reported number of recent hires [4-6 weeks post intervention]

      Average self-reported number of employees hired in the past month

    5. Self-reported number of employees [6-9 months post intervention]

      Average self-reported number of employees

    6. Self-Esteem using the Rosenberg Self-esteem Scale [4-6 weeks post intervention]

      Minimum score 10 and a maximum score of 40. Investigators will reverse code items 3,5,8,9 and 10 . Higher scores indicate high levels of self-esteem (better outcome)

    7. Self-Esteem using the Rosenberg Self-esteem Scale [6-9 months post intervention]

      Minimum score 10 and a maximum score of 40. Investigators will reverse code items 3,5,8,9 and 10. Higher scores indicate high levels of self-esteem (better outcome)

    8. World Health Organisation- Five Well-Being Index (WHO-5) [4-6 weeks post intervention]

      Minimum score of 0 and a maximum of 25. Higher scores mean better wellbeing (better outcome). Scores are transformed to 0-100 (by multiplying by 4.

    9. World Health Organisation- Five Well-Being Index (WHO-5) [6-9 months post intervention]

      Minimum score of 0 and a maximum of 25. Higher scores mean better wellbeing (better outcome). Scores are transformed to 0-100 (by multiplying by 4.

    10. Functional Impairment using the World Health Organization Disability Assessment Schedule (WHODAS-2.0 -12 item version) [6-9 months post intervention]

      Minimum score of 12 and a maximum of 60. Higher scores indicate high levels of disability (worse outcome)

    11. Functional Impairment using the World Health Organization Disability Assessment Schedule (WHODAS-2.0 -12 item version) [4-6 weeks post intervention]

      Minimum score of 12 and a maximum of 60. Higher scores indicate high levels of disability (worse outcome)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age ≥18;

    • Women entrepreneurs who obtained loan or business skills training from WEDP;

    • Those who have plan to live in Addis Ababa in the next six months;

    • Those who can read and speak Amharic and can understand the study questionnaire;

    • Those who have capacity to provide informed consent;

    • Score 8 or above on the Ethiopian adaptation of Kessler-6;

    Exclusion Criteria:
    • Kessler 6 score >20;

    • Those who have recent or current suicidal thoughts or plans;

    • Those who have limitation to understand the study questionnaire;

    • Those who have not capacity to provide informed consent;

    • Do not own a mobile phone;

    • Not interested in receiving the intervention

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 PSI and World Bank, Ethiopia Addis Ababa Ethiopia

    Sponsors and Collaborators

    • World Bank
    • Ethiopian Medical Association
    • Addis Ababa University
    • PSI Ethiopia

    Investigators

    • Principal Investigator: Naira Kalra, PhD, World Bank
    • Principal Investigator: Adiam Hailemicheal, MSc, World Bank
    • Principal Investigator: Kassahun Habtamu Mekonnen, PhD, Addis Ababa University
    • Principal Investigator: Medhin Selamu Tegegn, PhD, College of health science, Addis Ababa University, Ethiopia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    World Bank
    ClinicalTrials.gov Identifier:
    NCT05208723
    Other Study ID Numbers:
    • DWMTS
    First Posted:
    Jan 26, 2022
    Last Update Posted:
    Feb 15, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by World Bank
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 15, 2022